| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4K | -97.7% |
| Cost of Revenue | $4.0M | -43.6% |
| R&D Expense | $1.8M | +94.3% |
| SG&A Expense | $9.8M | +1.3% |
| Operating Income | -$15.6M | +10.8% |
| Interest Expense | $125K | +495.2% |
| Pre-tax Income | -$15.4M | +15.2% |
| Income Tax | $2K | +0.0% |
| Net Income | -$15.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | -13.0% |
| Accounts Receivable | $12K | -95.5% |
| Inventory | $278K | +126.0% |
| Current Assets | $23.2M | +86.6% |
| Total Assets | $33.5M | +0.7% |
| Current Liabilities | $12.3M | +201.9% |
| Total Liabilities | $12.6M | +119.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.1M | -33.3% |
| Capital Expenditures | $4.8M | +103.0% |
| Investing Cash Flow | -$3.4M | -53.5% |
| Financing Cash Flow | $12.5M | +9.3% |
| Free Cash Flow | -$14.9M | -49.7% |
| +15.2% |
| EPS (Basic) | -$0.20 | +23.1% |
| Stockholders' Equity |
| $20.9M |
| -24.0% |